Europe Medical Cannabis Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2024 –2031 |
Taille du marché (année de référence) |
USD 2,625.67 million |
Taille du marché (année de prévision) |
USD 24,646.06 million |
TCAC |
|
Principaux acteurs du marché |
>Marché européen du cannabis médical, par produit (huile, cannabis médical séché, capsules de cannabis médical, fleur entière, fleur moulue, stylo à vapotage, crèmes et hydratants, et autres), source (synthétique et naturelle), espèce (cannabis indica, sativa et hybride), dérivés (cannabidiol (CBD), tétrahydrocannabinol (THC) / delta-8-tétrahydrocannabinol et autres), application (gestion de la douleur, anxiété, spasmes musculaires, nausées, perte d'appétit, cancer, arthrite, maladie d'Alzheimer/migraines, épilepsie, dépression et troubles du sommeil, sclérose en plaques, autisme, problèmes de santé mentale, amélioration de l'humeur et autres), voie d'administration (solutions orales et capsules, tabagisme, vaporisateurs, produits topiques et autres), utilisateur final (industrie pharmaceutique, centres de recherche et développement, milieu de soins à domicile, hôpital, centre de réadaptation Centres et autres, canal de distribution (B2B et B2C) - Tendances et prévisions du secteur jusqu'en 2031.
Analyse et perspectives du marché du cannabis médical en Europe
Le cannabis légal est l'une des industries qui connaît la croissance la plus rapide dans les États européens, avec des implications majeures pour les industries agroalimentaires, textiles, chimiques et bien d'autres. Les graines de chanvre sont utilisées comme aliment nutritionnel depuis des milliers d'années. Ces graines contiennent très peu de THC (δ-9-tétrahydrocannabinol) et sont donc différentes de la marijuana médicinale.
Data Bridge Market Research analyse que le marché du cannabis médical devrait croître à un TCAC de 33,6 % au cours de la période de prévision de 2024 à 2031 et devrait atteindre 24 646,06 millions USD d'ici 2031 contre 2 625,67 millions USD d'ici 2023.
Rapport métrique |
Détails |
Période de prévision |
2024 à 2031 |
Année de base |
2023 |
Années historiques |
2022 (personnalisable pour 2016-2021) |
Unités quantitatives |
Chiffre d'affaires en millions USD |
Segments couverts |
Produit (huile, cannabis médical séché, capsules de cannabis médical, fleur entière, fleur moulue, stylo à vapotage, crèmes et hydratants, et autres), source (synthétique et naturelle), espèce (cannabis indica, sativa et hybride), dérivés ( cannabidiol (CBD), tétrahydrocannabinol (THC) / delta-8-tétrahydrocannabinol et autres), application (gestion de la douleur, anxiété, spasmes musculaires, nausées, perte d'appétit, cancer, arthrite , maladie d'Alzheimer / migraines, épilepsie, dépression et troubles du sommeil, sclérose en plaques, autisme, problèmes de santé mentale, amélioration de l'humeur et autres), voie d'administration (solutions orales et capsules, tabagisme, vaporisateurs, produits topiques et autres), utilisateur final (industrie pharmaceutique, centres de recherche et développement, soins à domicile, hôpital, centres de réadaptation, autres), canal de distribution (B2B et B2C) |
Pays couverts |
Allemagne, France, Royaume-Uni, Espagne, Italie, Turquie, Pays-Bas, Belgique, Suisse, Grèce, Luxembourg et reste de l'Europe |
Acteurs du marché couverts |
Tilray, Althea Company Pty Ltd (une filiale d'Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY et Sanity Group GmbH, entre autres |
Définition du marché européen du cannabis médical
Le cannabis est une drogue psychoactive dérivée de la plante de cannabis de la famille des Cannabaceae. Depuis plusieurs années, il est utilisé à des fins médicinales. Il possède un large éventail d'applications dans le traitement de diverses maladies, notamment la douleur chronique, le cancer, la dépression, le diabète, l'arthrite, le glaucome, l'épilepsie, les migraines, le sida et la maladie d'Alzheimer, entre autres.
Dynamique du marché européen du cannabis médical
Conducteurs
- Augmentation de la population gériatrique
La population gériatrique croissante à travers le monde est plus exposée aux maladies chroniques, qui nécessitent davantage de visites chez le médecin. La population vieillissante souffre de divers problèmes de santé, notamment le diabète, la dépression et la démence, entre autres. Le cannabis médical a les propriétés de traiter ces maladies, et par conséquent, la population croissante joue un rôle important.
- Augmentation de l'incidence des maladies nécessitant l'usage du cannabis
Les maladies chroniques sont des problèmes de santé courants dans le monde. À l’échelle mondiale, un adulte sur trois souffre de maladies chroniques. Les maladies neurologiques ont affecté la santé et la qualité de vie de nombreux citoyens. Les maladies neurologiques chroniques telles que la maladie d’Alzheimer, le cancer, les maladies inflammatoires chroniques de l’intestin et l’épilepsie peuvent entraîner une hospitalisation, une invalidité à long terme, une diminution de la qualité de vie et la mort.
Le cannabis est un terme générique utilisé pour désigner les différentes préparations psychoactives de la plante Cannabis sativa. Le cannabis a été utilisé à des fins médicinales ou récréatives. Étant donné que les cannabinoïdes réagissent avec les récepteurs du système nerveux, les chercheurs pensent que les cannabinoïdes peuvent être utiles dans le traitement d'autres troubles neurologiques. Le cannabis médical est sûr et efficace pour améliorer les symptômes tels que la douleur, les troubles du sommeil et l'anxiété dus aux maladies chroniques chez les personnes âgées.
Opportunités
- Initiatives stratégiques des acteurs du marché
En Europe, le besoin de médicaments pour traiter les troubles du genou a augmenté en raison de l'augmentation de la prévalence et de l'incidence des troubles chroniques du genou, des thérapies avancées pour l'arthrose du genou et les lésions méniscales, et des besoins médicaux non satisfaits. Ces facteurs (tels que l'augmentation de l'incidence, des cas de troubles chroniques du genou et de la disponibilité des thérapies avancées) renforcent la nécessité d'une thérapie de rééducation orthopédique, et pour répondre à la demande du marché, les acteurs mineurs et majeurs du marché utilisent diverses stratégies.
- Développement de nouveaux produits avec des activités de recherche et développement (R&D) croissantes
La forte croissance de la demande de cannabis avec la légalisation a accru la nécessité de proposer de meilleures variétés de produits et de meilleurs systèmes de distribution. Cela a conduit de nombreuses entreprises à mener des activités de recherche et développement pour vérifier les stratégies d'amélioration génétique du cannabis.
Les entreprises se concentrent sur le développement de variétés à haut rendement, une meilleure tolérance aux herbicides, une faible teneur en THC et de meilleures qualités de récolte et de commercialisation des cultures de cannabis. L'amélioration des variétés entraînera la production d'une meilleure qualité de cannabis, ce qui créera une demande accrue de graines de bonne qualité. Par conséquent, le développement de nouveaux produits devrait constituer une opportunité pour le marché.
Contraintes/Défis
• Effets secondaires à long et à court terme liés à la consommation de cannabis et à la surconsommation de cannabis
Les spécialistes orthopédiques observent certains risques liés à l'utilisation des implants et à la prise de médicaments. Les opérations de remplacement du genou entraînent des complications qui découlent de la chirurgie ou d'un implant défectueux. Le desserrage de l'implant est l'une des complications les plus graves après une opération du genou, et la douleur est la plus courante. Le desserrage peut provoquer des fractures osseuses, une instabilité et des chutes graves. Presque toutes les complications graves nécessitent une intervention chirurgicale de révision. Les risques encourus sont les risques mécaniques, le desserrage de l'implant du genou et la douleur physique.
La marijuana est la deuxième drogue psychotrope la plus consommée après l'alcool. La consommation de résines riches en THC, extraites de la plante de cannabis, est en hausse et a provoqué de graves problèmes d'urgence pour les consommateurs.
- Pénurie de personnel qualifié
L'industrie du cannabis est confrontée non seulement à des pénuries d'approvisionnement, à des restrictions de produits et à des réglementations strictes, mais également à un manque de personnel qualifié pour faire fonctionner l'industrie sans problème. L'industrie du cannabis doit faire face à des préoccupations émergentes concernant les candidats et à la pénurie de personnel qualifié. De la stigmatisation liée au travail avec des substances auparavant interdites à l'expertise et à la sécurité, tous ces défis sont relevés par l'industrie.
Développement récent
- En mai 2020, Tilray a annoncé avoir reçu la certification GMP selon les normes de l'Union européenne, ce qui permet à l'usine de fabriquer des extraits de cannabis médical en interne et d'exporter des produits finis à base de cannabis médical. Cela a aidé l'entreprise à développer ses activités
- En février 2022, Sanity Group GmbH, un segment d'activité de Sanity Medical, a conclu un accord avec la plateforme de télémédecine Telaleaf pour renforcer la télémédecine dans la thérapie au cannabis en Allemagne
Portée du marché européen du cannabis médical
Le marché européen du cannabis médical est segmenté en fonction du produit, de la source, de l'espèce, des dérivés, de l'application, de la voie d'administration, de l'utilisateur final et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Produit
- Huile
- Cannabis médical séché
- Gélules de cannabis médical
- Stylo à vapotage
- Fleur entière
- Crèmes et hydratants
- Fleur de terre
- Autres
Sur la base du produit, le marché est segmenté en huile, capsules de cannabis médical, fleur entière, fleur moulue, stylo vape, cannabis médical séché, crèmes et hydratants, et autres.
Source
- Naturel
- Synthetic
On the basis of source, the market is segmented into synthetic and natural.
Species
- Sativa
- Hybrid
- Cannabis Indica
On the basis of species, the market is segmented into sativa, hybrid, and cannabis indica.
Derivatives
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
- Others
On the basis of derivatives, the market is segmented into Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, and others.
Application
- Pain Management
- Anxiety
- Muscle Spasms
- Nausea
- Appetite Loss
- Cancer
- Arthritis
- Alzheimer's Disease/Migranes
- Epilepsy
- Depression and Sleep Disorders
- Multiple Sclerosis
- Autism
- Mental Health Conditions
- Elevate Modd
- Others
On the basis of application, the market is segmented into pain management, anxiety, muscle spasms, nausea, appetite loss, cancer, arthritis, alzheimer's disease/migranes, epilepsy, depression and sleep disorders, multiple sclerosis, autism, mental health conditions, elevate modd, and others.
Route of Administration
- Oral Solution and Capsules
- Smoking
- Topicals
- Vaporizers
- Others
On the basis of route of administration, the market is segmented into oral solution and capsules, smoking, topicals, vaporizers, and others.
End User
- Homecare Setting
- Hospital
- Rehab Centers
- Pharmaceutical Industry
- Research and Development Centers
- Others
On the basis of end user, the market is segmented into homecare setting, hospital, rehab centers, pharmaceutical industry, research and development centers, and others.
Distribution Channel
- B2C
- B2B
On the basis of distribution channel, the market is segmented into B2C and B2B.
Europe Medical Cannabis Market: Regional Analysis/Insights
The Europe medical cannabis market is segmented on the basis of product, source, species, derivatives, application, route of administration, end user, and distribution channel.
The countries covered in the Europe medical cannabis market report are Germany, France, U.K., Spain, Italy, Turkey, Netherlands, Belgium, Switzerland, Greece, Luxembourg, and rest of Europe.
Germany is expected to dominate the market due to a rise in knee osteoarthritis, knee arthroplasty surgeries, and various orthopedic centers in Germany.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Share Analysis: Europe Medical Cannabis Market
Le paysage concurrentiel du marché européen du cannabis médical fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché européen du cannabis médical.
Certains des principaux acteurs opérant sur le marché européen du cannabis médical sont Tilray, Althea Company Pty Ltd (une filiale d'Althea Group Holdings Limited), PharmaHemp, Aurora Cannabis Inc., CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., EcoGen Biosciences, GRASS & CO., CANNARAY et Sanity Group GmbH, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe MEDICAL CANNABIS market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market application coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- EUROPE MEDICAL CANNABIS MARKET: REGULATIONS
- UNITED STATES
- CANADA
- AUSTRALIA
- THAILAND
- EUROPE MEDICAL CANNABIS MARKET: SUPPLY CHAIN ANALYSIS
- CULTIVATORS AND GROWERS
- MANUFACTURER AND PRODUCER
- TESTERS
- WHOLESALE AND DISTRIBUTORS
- RETAILERS
- Market Overview
- DRIVERS
- INCREASED MEDICINAL USE
- LEGALIZATION OF CANNABIS
- INITIATIVES TAKEN BY MANUFACTURERS
- INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
- FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
- RESTRAINTS
- COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
- LONG TERM USE CAN CAUSE ADVERSE EFFECTS
- HIGH COST
- OPPORTUNITIES
- NOVEL PRODUCT DEVELOPMENT WITH INCREASING R & D ACTIVITIES
- INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSE
- GROWING GERIATRIC POPULATION
- INCREASING PREVALENCE OF CHRONIC DISEASES
- CHALLENGES
- RISE OF MARIJUANA BLACK MARKET
- SIDE EFFECTS RELATED TO THE USE OF CANNABIS
- SHORTAGE OF PERSONNEL
- IMPACT OF COVID-19 ON EUROPE MEDICAL CANNABIS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY
- KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
- CONCLUSION:
- EUROPE MEDICAL CANNABIS MARKET, BY product
- overview
- oil
- By Type
- CBD Oil Concentrates
- CBD Vape Oil
- CBD Tinctures
- By Source
- Marijuana Based
- Hemp Based
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- Dried Medical cannabis
- Cannabis Indica
- Sativa
- Hybrid
- medical cannabis capsules
- By Type
- Oil Based Cannabis Capsules
- Power Based Cannabis Capsules
- Others
- By Concentrates
- High CBD Capsules Digital
- High THC Capsule
- THC/CBD balanced capsule
- CBD Isolate Capsule
- By Species
- Sativa
- Hybrid
- Cannabis Indica
- vape pen
- Cannabis Indica
- Sativa
- Hybrid
- whole flower
- Sativa
- Hybrid
- Cannabis Indica
- CREAMS & MOISTURIZER
- Ground Flower
- Sativa
- Cannabis Indica
- Hybrid
- patch
- mask & serum
- cleanser
- others
- EUROPE MEDICAL CANNABIS MARKET, BY application
- overview
- pain management
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- anxiety
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- muscle spasms
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Creams & Moisturizer
- Ground Flower
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- nausea
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Creams & Moisturizer
- Patch
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- appetite loss
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Ground Flower
- Whole Flower
- Vape Pen
- Patch
- Others
- cancer
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- arthritis
- Oil
- Medical cannabis and capsules
- Dried Medical Cannabis
- Patch
- Ground Flower
- Creams & Moisturizer
- Masks & Serum
- Whole Flower
- Vape Pen
- Cleanser
- Others
- alzheimer’s disease/Migranes
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- epilepsy
- Oil
- Medical cannabis and capsules
- Others
- depression and sleep disorders
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Others
- multiple sclerosis
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Ground Flower
- Vape Pen
- Whole Flower
- Others
- autism
- Oil
- Medical cannabis and capsules
- Others
- mental health conditions
- Oil
- Medical cannabis and capsules
- Others
- elevate Mood
- Oil
- Dried Medical Cannabis
- Medical cannabis and capsules
- Patch
- Creams & Moisturizer
- Masks & Serum
- Cleanser
- Others
- others
- EUROPE MEDICAL CANNABIS MARKET, BY derivatives
- overview
- CANNABIDIOL (CBD)
- Oil
- Medical Cannabis Capsules
- Ground Flower
- Patch
- Creams & Moisturizer
- Vape Pen
- Whole Flower
- Masks & Serum
- Cleanser
- Others
- tetrahydrocannabinol (thc)/Delta-8-TETRAHYDROCANNABINOL
- Oil
- Medical Cannabis Capsules
- Dried Medical Cannabis
- Ground Flower
- Patch
- Creams & Moisturizer
- Whole Flower
- Vape Pen
- Masks & Serum
- Cleanser
- Others
- CANNABIGEROL (CBG)
- Oil
- Whole Flower
- Medical cannabis and capsules
- Cleanser
- cannabinol (CBN)
- others
- EUROPE MEDICAL CANNABIS MARKET, BY source
- overview
- natural
- synthetic
- EUROPE MEDICAL CANNABIS MARKET, BY species
- overview
- sativa
- hybrid
- cannabis indica
- EUROPE MEDICAL CANNABIS MARKET, BY route of administration
- overview
- oral solutions and capsules
- smoking
- topicals
- vaporizers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY end user
- overview
- homecare setting
- hospital
- rehab centers
- PHARMACEUTICAL INDUSTRY
- research and development centers
- others
- EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
- overview
- B2C
- Pharmacies
- Conventional Stores
- Online Stores
- Others
- B2B
- Europe medical cannabis MARKET by geography
- europe
- germany
- italy
- u.k.
- NETHERLANDS
- switzerland
- france
- russia
- spain
- belgium
- rest of europe
- Europe Medical Cannabis market: COMPANY landscape
- company share analysis: Europe
- Swot analysis
- company profile
- MEDIPHARM LABS INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- APHRIA INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- tilray
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Zenabis Europe Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AURORA CANNABIS
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- gw pharmaceuticals plc
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Althea Company Pty Ltd (A subsidiary of Althea Group)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Apothecanna
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bARNEY’S FARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bioactive solutions, inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bol pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CANNABIS SEEDS USA
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- canopy growth corporation
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Cresco Labs
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Crop King Seeds
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- discover health llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- EcoGen Biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Elixinol Europe limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- endoca
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- EXTRACTAS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FOLIUM BIOSCIENCES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GREENWICH BIOSCIENCES, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HARMONY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMBOLDT SEED COMPANY
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- IDT AUSTRALIA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- kiehl’s (a subsidiary of L'Oréal)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- mary’s nutritionals, LLC
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- medical marijuana, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MEDIFARM
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pacific roots
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pharmahemp
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pure ratios
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- PEACE NATURALS PROJECT INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- seed Cellar
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SEEDS FOR ME
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- THC EUROPE GROUP LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- upstate elevator supply co.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- vermont hemp health
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Liste des tableaux
TABLE 1 Annual Cost of Cultivation:
TABLE 2 Annual Cost of Manufacturing:
TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED
TABLE 26 Europe MEDICAL CANNABIS market, By application, 2019-2028 (USD million)
TABLE 27 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 28 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 29 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS market, by anxiety, By Region, 2021-2028 (USD Million)
TABLE 30 Europe Pain Management in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 31 EUROPE muscle spasms IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 32 Europe muscle spasms in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 33 EUROPE nausea IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 34 Europe nausea in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 35 EUROPE appetite loss IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 36 Europe appetite loss in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 37 EUROPE cancer IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 38 Europe cancer in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 39 EUROPE arthritis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 40 Europe arthritis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 41 EUROPE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 42 Europe ALZHEIMER’S DISEASE/MIGRANES in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 43 EUROPE epilepsy IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 44 Europe epilepsy in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 45 EUROPE depression and sleep disorders IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 46 Europe depression and sleep disorders in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 47 EUROPE multiple sclerosis IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 48 Europe multiple sclerosis in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 49 EUROPE autism IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 50 Europe autism in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 51 EUROPE mental health conditions IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 52 Europe mental health conditions in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 53 EUROPE elevate mood IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 54 Europe elevate mood in Medical Cannabis Market , By Application, 2019-2028 (USD Million)
TABLE 55 EUROPE others IN MEDICAL CANNABIS market, by PAIN MANAGEMENT, By Region, 2021-2028 (USD Million)
TABLE 65 Europe medical cannabis Market, BY source, 2019-2028 (USD MILLION)
TABLE 66 Europe natural in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 67 Europe synthetic in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 68 Europe medical cannabis Market, By Species, 2019-2028 (USD Million)
TABLE 69 Europe sativa in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 70 Europe hybrid in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 71 Europe cannabis indica in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 72 Europe medical cannabis Market, By route of administration, 2019-2028 (USD Million)
TABLE 73 Europe oral solutions and capsules in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 74 Europe smoking in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 75 Europe topicals in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 76 Europe vaporizers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 77 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 78 Europe medical cannabis Market, BY end user, 2019-2028 (USD MILLION)
TABLE 79 Europe homecare setting in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 80 Europe hospital in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 81 Europe rehab centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 82 Europe pharmaceutical industry in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 83 Europe research and development centers in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 84 Europe others in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 85 Europe medical cannabis Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)
TABLE 86 Europe b2c in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 87 Europe b2C in medical cannabis Market, By distribution channel, 2019-2028 (USD Million)
TABLE 88 Europe b2b in medical cannabis Market, By Region, 2019-2028 (USD Million)
TABLE 89 europe medical cannabis Market, By COUNTRY, 2021-2028 (USD million)
TABLE 90 EUROPE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 91 EUROPE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 92 EUROPE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 93 EUROPE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 94 EUROPE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 95 EUROPE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 96 EUROPE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 97 EUROPE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 98 EUROPE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 99 EUROPE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 100 EUROPE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 101 EUROPE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 102 EUROPE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 103 EUROPE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 104 EUROPE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 105 EUROPE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 106 EUROPE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 107 EUROPE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 108 EUROPE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 109 EUROPE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 110 EUROPE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 111 EUROPE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 112 EUROPE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 113 EUROPE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 114 EUROPE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 115 EUROPE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 116 EUROPE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 117 EUROPE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 118 EUROPE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 119 EUROPE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 120 EUROPE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 121 EUROPE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 122 EUROPE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 123 EUROPE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 124 EUROPE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 125 EUROPE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 126 GERMANY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 127 GERMANY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 128 GERMANY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 129 GERMANY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 130 GERMANY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 131 GERMANY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 132 GERMANY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 133 GERMANY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 134 GERMANY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 135 GERMANY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 136 GERMANY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 137 GERMANY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 138 GERMANY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 139 GERMANY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 140 GERMANY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 141 GERMANY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 142 GERMANY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 143 GERMANY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 144 GERMANY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 145 GERMANY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 146 GERMANY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 147 GERMANY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 148 GERMANY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 149 GERMANY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 150 GERMANY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 151 GERMANY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 152 GERMANY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 153 GERMANY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 154 GERMANY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 155 GERMANY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 156 GERMANY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 157 GERMANY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 158 GERMANY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 159 GERMANY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 160 GERMANY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 161 GERMANY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 162 ITALY medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 163 ITALY type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 164 ITALY source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 165 ITALY species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 166 ITALY dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 167 ITALY type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 168 ITALY concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 169 ITALY species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 170 ITALY vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 171 ITALY whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 172 ITALY ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 173 ITALY medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 174 ITALY medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 175 ITALY medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 176 ITALY cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 177 ITALY tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 178 ITALY cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 179 ITALY medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 180 ITALY pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 181 ITALY anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 182 ITALY muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 183 ITALY nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 184 ITALY appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 185 ITALY cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 186 ITALY arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 187 ITALY alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 188 ITALY epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 189 ITALY depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 190 ITALY multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 191 ITALY autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 192 ITALY mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 193 ITALY elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 194 ITALY medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 195 ITALY medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 196 ITALY medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 197 ITALY B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 198 U.K. medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 199 U.K. type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 200 U.K. source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 201 U.K. species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 202 U.K. dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 203 U.K. type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 204 U.K. concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 205 U.K. species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 206 U.K. vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 207 U.K. whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 208 U.K. ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 209 U.K. medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 210 U.K. medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 211 U.K. medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 212 U.K. cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 213 U.K. tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 214 U.K. cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 215 U.K. medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 216 U.K. pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 217 U.K. anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 218 U.K. muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 219 U.K. nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 220 U.K. appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 221 U.K. cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 222 U.K. arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 223 U.K. alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 224 U.K. epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 225 U.K. depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 226 U.K. multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 227 U.K. autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 228 U.K. mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 229 U.K. elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 230 U.K. medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 231 U.K. medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 232 U.K. medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 233 U.K. B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 234 NETHERLANDS medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 235 NETHERLANDS type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 236 NETHERLANDS source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 237 NETHERLANDS species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 238 NETHERLANDS dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 239 NETHERLANDS type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 240 NETHERLANDS concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 241 NETHERLANDS species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 242 NETHERLANDS vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 243 NETHERLANDS whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 244 NETHERLANDS ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 245 NETHERLANDS medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 246 NETHERLANDS medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 247 NETHERLANDS medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 248 NETHERLANDS cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 249 NETHERLANDS tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 250 NETHERLANDS cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 251 NETHERLANDS medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 252 NETHERLANDS pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 253 NETHERLANDS anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 254 NETHERLANDS muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 255 NETHERLANDS nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 256 NETHERLANDS appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 257 NETHERLANDS cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 258 NETHERLANDS arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 259 NETHERLANDS alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 260 NETHERLANDS epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 261 NETHERLANDS depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 262 NETHERLANDS multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 263 NETHERLANDS autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 264 NETHERLANDS mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 265 NETHERLANDS elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 266 NETHERLANDS medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 267 NETHERLANDS medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 268 NETHERLANDS medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 269 NETHERLANDS B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 270 SWITZERLAND medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 271 SWITZERLAND type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 272 SWITZERLAND source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 273 SWITZERLAND species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 274 SWITZERLAND dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 275 SWITZERLAND type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 276 SWITZERLAND concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 277 SWITZERLAND species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 278 SWITZERLAND vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 279 SWITZERLAND whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 280 SWITZERLAND ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 281 SWITZERLAND medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 282 SWITZERLAND medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 283 SWITZERLAND medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 284 SWITZERLAND cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 285 SWITZERLAND tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 286 SWITZERLAND cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 287 SWITZERLAND medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 288 SWITZERLAND pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 289 SWITZERLAND anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 290 SWITZERLAND muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 291 SWITZERLAND nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 292 SWITZERLAND appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 293 SWITZERLAND cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 294 SWITZERLAND arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 295 SWITZERLAND alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 296 SWITZERLAND epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 297 SWITZERLAND depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 298 SWITZERLAND multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 299 SWITZERLAND autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 300 SWITZERLAND mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 301 SWITZERLAND elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 302 SWITZERLAND medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 303 SWITZERLAND medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 304 SWITZERLAND medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 305 SWITZERLAND B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 306 FRANCE medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 307 FRANCE type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 308 FRANCE source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 309 FRANCE species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 310 FRANCE dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 311 FRANCE type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 312 FRANCE concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 313 FRANCE species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 314 FRANCE vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 315 FRANCE whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 316 FRANCE ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 317 FRANCE medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 318 FRANCE medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 319 FRANCE medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 320 FRANCE cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 321 FRANCE tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 322 FRANCE cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 323 FRANCE medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 324 FRANCE pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 325 FRANCE anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 326 FRANCE muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 327 FRANCE nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 328 FRANCE appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 329 FRANCE cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 330 FRANCE arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 331 FRANCE alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 332 FRANCE epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 333 FRANCE depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 334 FRANCE multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 335 FRANCE autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 336 FRANCE mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 337 FRANCE elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 338 FRANCE medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 339 FRANCE medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 340 FRANCE medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 341 FRANCE B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 342 RUSSIA medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 343 RUSSIA type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 344 RUSSIA source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 345 RUSSIA species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 346 RUSSIA dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 347 RUSSIA type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 348 RUSSIA concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 349 RUSSIA species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 350 RUSSIA vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 351 RUSSIA whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 352 RUSSIA ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 353 RUSSIA medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 354 RUSSIA medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 355 RUSSIA medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 356 RUSSIA cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 357 RUSSIA tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 358 RUSSIA cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 359 RUSSIA medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 360 RUSSIA pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 361 RUSSIA anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 362 RUSSIA muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 363 RUSSIA nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 364 RUSSIA appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 365 RUSSIA cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 366 RUSSIA arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 367 RUSSIA alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 368 RUSSIA epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 369 RUSSIA depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 370 RUSSIA multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 371 RUSSIA autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 372 RUSSIA mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 373 RUSSIA elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 374 RUSSIA medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 375 RUSSIA medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 376 RUSSIA medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 377 RUSSIA B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 378 SPAIN medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 379 SPAIN type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 380 SPAIN source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 381 SPAIN species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 382 SPAIN dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 383 SPAIN type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 384 SPAIN concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 385 SPAIN species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 386 SPAIN vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 387 SPAIN whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 388 SPAIN ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 389 SPAIN medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 390 SPAIN medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 391 SPAIN medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 392 SPAIN cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 393 SPAIN tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 394 SPAIN cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 395 SPAIN medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 396 SPAIN pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 397 SPAIN anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 398 SPAIN muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 399 SPAIN nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 400 SPAIN appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 401 SPAIN cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 402 SPAIN arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 403 SPAIN alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 404 SPAIN epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 405 SPAIN depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 406 SPAIN multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 407 SPAIN autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 408 SPAIN mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 409 SPAIN elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 410 SPAIN medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 411 SPAIN medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 412 SPAIN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 413 SPAIN B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 414 BELGIUM medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 415 BELGIUM type in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 416 BELGIUM source in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 417 BELGIUM species in oil in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 418 BELGIUM dried medical cannabs in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 419 BELGIUM type in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 420 BELGIUM concentrates in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 421 BELGIUM species in medical cannabis capsules in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 422 BELGIUM vape pen in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 423 BELGIUM whole flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 424 BELGIUM ground flower in medical cannabis Market, By product, 2021-2028 (USD million)
TABLE 425 BELGIUM medical cannabis Market, By source, 2021-2028 (USD million)
TABLE 426 BELGIUM medical cannabis Market, By species, 2021-2028 (USD million)
TABLE 427 BELGIUM medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 428 BELGIUM cannabidiol (cbd) medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 429 BELGIUM tetrahydrocannabinol (thc)/delt-8-tethydrocannabinol in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 430 BELGIUM cannabigerol (cbg) in medical cannabis Market, By derivatives, 2021-2028 (USD million)
TABLE 431 BELGIUM medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 432 BELGIUM pain management in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 433 BELGIUM anxiety in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 434 BELGIUM muscle spasms in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 435 BELGIUM nausea in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 436 BELGIUM appetite loss in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 437 BELGIUM cancer in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 438 BELGIUM arthritis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 439 BELGIUM alzheimer’s disease/migranes in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 440 BELGIUM epilepsy in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 441 BELGIUM depression and sleep disroder in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 442 BELGIUM multiple sclerosis in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 443 BELGIUM autism in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 444 BELGIUM mental health conditions in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 445 BELGIUM elevate mood in medical cannabis Market, By application, 2021-2028 (USD million)
TABLE 446 BELGIUM medical cannabis Market, By route of administration, 2021-2028 (USD million)
TABLE 447 BELGIUM medical cannabis Market, By end user, 2021-2028 (USD million)
TABLE 448 BELGIUM medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 449 BELGIUM B2C IN medical cannabis Market, By distribution channel, 2021-2028 (USD million)
TABLE 450 rest of europe medical cannabis Market, By product, 2021-2028 (USD million)
Liste des figures
FIGURE 1 Europe medical cannabis market: segmentation
FIGURE 2 Europe medical cannabis market: data triangulation
FIGURE 3 Europe medical cannabis market: DROC ANALYSIS
FIGURE 4 Europe medical cannabis market : Europe vs REGIONAL MARKET ANALYSIS
FIGURE 5 Europe medical cannabis market : COMPANY RESEARCH ANALYSIS
FIGURE 6 Europe medical cannabis market: INTERVIEW DEMOGRAPHICS
FIGURE 7 Europe medical cannabis market: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE medical cannabis MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 Europe medical cannabis market: vendor share analysis
FIGURE 10 Europe medical cannabis market: SEGMENTATION
FIGURE 11 increasing medicinal use and legalization of medical cannabis are expected to drive THE Europe medical cannabis market IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 oil segment is expected to account for the largest share of the Europe medical cananbis market in 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MEDICAL CANNABIS MARKET
FIGURE 14 Europe MEDICAL CANNABIS market: BY product, 2020
FIGURE 15 Europe MEDICAL CANNABIS market: BY product, 2021-2028 (USD Million)
FIGURE 16 Europe MEDICAL CANNABIS market: BY product, CAGR (2021-2028)
FIGURE 17 Europe MEDICAL CANNABIS market: BY product, LIFELINE CURVE
FIGURE 18 Europe MEDICAL CANNABIS market: BY application, 2020
FIGURE 19 Europe MEDICAL CANNABIS market: BY application, 2021-2028 (USD Million)
FIGURE 20 Europe MEDICAL CANNABIS market: BY application, CAGR (2021-2028)
FIGURE 21 Europe MEDICAL CANNABIS market: BY application, LIFELINE CURVE
FIGURE 22 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2020
FIGURE 23 Europe MEDICAL CANNABIS market: BY DERIVATIVES, 2021-2028 (USD Million)
FIGURE 24 Europe MEDICAL CANNABIS market: BY DERIVATIVES, CAGR (2021-2028)
FIGURE 25 Europe MEDICAL CANNABIS market: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 Europe MEDICAL CANNABIS market: BY source, 2020
FIGURE 27 Europe MEDICAL CANNABIS market: BY source, 2021-2028 (USD Million)
FIGURE 28 Europe MEDICAL CANNABIS market: BY source, CAGR (2021-2028)
FIGURE 29 Europe MEDICAL CANNABIS market: BY source, LIFELINE CURVE
FIGURE 30 Europe MEDICAL CANNABIS market: BY species, 2020
FIGURE 31 Europe MEDICAL CANNABIS market: BY species, 2021-2028 (USD Million)
FIGURE 32 Europe MEDICAL CANNABIS market: BY species, CAGR (2021-2028)
FIGURE 33 Europe MEDICAL CANNABIS market: BY species, LIFELINE CURVE
FIGURE 34 Europe MEDICAL CANNABIS market: BY route of administration, 2020
FIGURE 35 Europe MEDICAL CANNABIS market: BY route of administration, 2021-2028 (USD Million)
FIGURE 36 Europe MEDICAL CANNABIS market: BY route of administration, CAGR (2021-2028)
FIGURE 37 Europe MEDICAL CANNABIS market: BY route of administration, LIFELINE CURVE
FIGURE 38 Europe MEDICAL CANNABIS market: BY end user, 2020
FIGURE 39 Europe MEDICAL CANNABIS market: BY end user, 2021-2028 (USD Million)
FIGURE 40 Europe MEDICAL CANNABIS market: BY end user, CAGR (2021-2028)
FIGURE 41 Europe MEDICAL CANNABIS market: BY end user, LIFELINE CURVE
FIGURE 42 Europe MEDICAL CANNABIS market: BY distribution channel, 2020
FIGURE 43 Europe MEDICAL CANNABIS market: BY distribution channel , 2021-2028 (USD Million)
FIGURE 44 Europe MEDICAL CANNABIS market: BY distribution channel , CAGR (2021-2028)
FIGURE 45 Europe MEDICAL CANNABIS market: BY distribution channel, LIFELINE CURVE
FIGURE 46 europe medical cannabis MARKET: SNAPSHOT (2020)
FIGURE 47 europe medical cannabis MARKET: BY COUNTRY (2020)
FIGURE 48 europe medical cannabis MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 europe medical cannabis MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 europe medical cannabis MARKET: BY type (2021-2028)
FIGURE 51 Europe Medical Cannabis market: company share 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.